Next Financial Group’s Adaptimmune Therapeutics ADAP Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2021
Q4 | $2K | Hold |
475
| – | – | ﹤0.01% | 2579 |
|
|
2021
Q3 | $2K | Hold |
475
| – | – | ﹤0.01% | 2440 |
|
|
2021
Q2 | $2K | Hold |
475
| – | – | ﹤0.01% | 2370 |
|
|
2021
Q1 | $3K | Hold |
475
| – | – | ﹤0.01% | 2198 |
|
|
2020
Q4 | $3K | Hold |
475
| – | – | ﹤0.01% | 2070 |
|
|
2020
Q3 | $4K | Buy |
+475
| New | +$4K | ﹤0.01% | 1881 |
|
|
2020
Q2 | – | Sell |
-475
| Closed | -$1K | – | 606 |
|
|
2020
Q1 | $1K | Hold |
475
| – | – | ﹤0.01% | 1977 |
|
|
2019
Q4 | $1K | Hold |
475
| – | – | ﹤0.01% | 2245 |
|
|
2019
Q3 | $1K | Hold |
475
| – | – | ﹤0.01% | 2184 |
|
|
2019
Q2 | $2K | Hold |
475
| – | – | ﹤0.01% | 2083 |
|
|
2019
Q1 | $2K | Hold |
475
| – | – | ﹤0.01% | 1423 |
|
|
2018
Q4 | $3K | Hold |
475
| – | – | ﹤0.01% | 1649 |
|
|
2018
Q3 | $6K | Buy |
+475
| New | +$6K | ﹤0.01% | 1115 |
|